2007 News
-
Press Release
-
Press Release
Agreement Concerning Glaucoma and Ocular HypertensionTreatment RESCULA® Eye Drops
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)
-
IR News
Resolution Notice of The 95th Annual General Meeting of Shareholders
-
Press Release IR News
Notice on the Allotment of Stock Options (Stock Acquisition Rights)
-
Press Release IR News
Convocation Notice of the 95th Annual General Meeting of Shareholders
-
Press Release IR News
-
Press Release IR News
Santen to Issue Stock Acquisition Rights to the Directors for the Purpose of Granting Stock Options
-
Press Release IR News
Santen Announces Financial Results for the Year ended March 31,2007
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Santen Oy Submits Marketing Approval for Glaucoma and Ocular Hypertension Drug Candidate DE-085
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
-
Press Release IR News
Santen Announces Financial Result for the Third Quarter ended December31, 2006